5H4-32013-04944
5 vaccinations
6 coded responses
28 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 113 / NY
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
RC2-20564-99639
Child or adolescent in my care · Female · 2022-06-22
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
- 2021-03-30
-
2021-03-31
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
-
2021-04-20
Dose 2 — Pfizer-BioNTech
- 2021-04-20
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-04-25
-
2021-04-26
Survey response — days 1–6 daily, dose 2MedDRA: Dysmenorrhoea, Menstruation irregular — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Early and worse cramps than usual periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-27
-
2021-05-04
Survey response — day 14, dose 2MedDRA: Injection site erythema, Injection site pruritus — Feeling: GoodFree text: Red patch and itchiness at injection site comes and goesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-11
-
2021-05-18
Survey response — day 28, dose 2MedDRA: Pain in extremity, Paraesthesia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Calf pain, feet tinglingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-18
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-25
- 2021-06-01
-
2021-07-20
Survey response — 3 months, dose 2MedDRA: Gingival pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Gum painMedDRA releases: 2024-11 · check-in free text available
- 2021-10-19
-
2021-12-31
Dose 3 — Pfizer-BioNTech
-
2022-04-18
Call successfulNot applicable - Accidental Reporting
- 2022-04-22
- 2022-07-01
-
2022-07-24
Dose 4 — Pfizer-BioNTech
-
2022-09-26
Dose 5 — Pfizer-BioNTech
- 2022-12-31
-
2023-03-27
Survey response — 6 months, dose 5MedDRA: Nasopharyngitis, Sinusitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-27
Report sent to call center — 6 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-03-28
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-12-31 | Pfizer-BioNTech | No |
| 4 | 2022-07-24 | Pfizer-BioNTech | No |
| 5 | 2022-09-26 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-18 | Successful 2022-04-18 |
Not applicable - Accidental Reporting |
| 2023-03-27 | Successful 2023-03-28 |
Not applicable - Accidental Reporting |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Early and worse cramps than usual period
Release 8 — day 14, dose 2
Symptoms: Red patch and itchiness at injection site comes and goes
Release 8 — day 28, dose 2
Symptoms: Calf pain, feet tingling
Release 9 — 3 months, dose 2
Symptoms: Gum pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gingival pain | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SRO | Menstruation irregular | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release